Header Logo

Connection

CHARLES MINARD to Doxorubicin

Back to Details
This is a "connection" page, showing publications CHARLES MINARD has written about Doxorubicin.
CHARLES MINARD
Connection Strength
0.028
Doxorubicin
  1. Safety, tolerability and pharmacokinetics of crizotinib in combination with cytotoxic chemotherapy for pediatric patients with refractory solid tumors or anaplastic large cell lymphoma (ALCL): a Children's Oncology Group phase 1 consortium study (ADVL1212). Cancer Chemother Pharmacol. 2020 12; 86(6):829-840.
    View in: PubMed
    Score: 0.028
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.